Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline
Jia Huang,1 Yun Wang,1 Jun Chen,1 Yanlei Zhang,2 Zheng Yuan,2 Li Yue,2 Josep Maria Haro,3 Maria Victoria Moneta,3 Diego Novick,4 Yiru Fang1,5,6 1Division of Mood Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 2Medical Department, Eli Lil...
Saved in:
Main Authors: | Huang J, Wang Y, Chen J, Zhang Y, Yuan Z, Yue L, Haro JM, Moneta MV, Novick D, Fang YR |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/bb7b29fd6d9e4e7ba39a12595ce76382 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia
by: Novick D, et al.
Published: (2016) -
Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial
by: Kishi T, et al.
Published: (2017) -
Impact of anxiety symptoms on outcomes of depression: an observational study in Asian patients
by: Novick D, et al.
Published: (2016) -
Escitalopram vs duloxetine in acute treatment of major depressive disorder: meta-analysis and systematic review
by: Maneeton B, et al.
Published: (2018) -
Comparison of duloxetine and SSRI as a treatment option of painful physical symptoms associated with major depressive disorder
by: Haider M, et al.
Published: (2017)